Inter-Agency Vaccine Group / M.P.H. Health Resources / Risks Phase 4 Human Studies Additional Safety Manufacturing / Vaccine Manufacturing / Non-Federal Vaccine Safety Partners / Immunogen / /
Country
Italy / Sweden / Japan / United States / Canada / Australia / United Kingdom / /
Event
FDA Phase / /
Facility
Facility Assessment Requirements / Institute of Medicine Safety Reviews / Institute of Medicine / /
IndustryTerm
manufacturing process controls / therapeutic medical products / cell culture systems / barrier isolator systems / manufacturing technology / manufacturing processes / manufacturing process / chemical and biological methods / sterile connecting devices / manufacturing / healthcare providers / /
MedicalCondition
alleged vaccine injury / smallpox / diphtheria / tetanus / anaphylaxis / hepatitis B / eczema vaccinatum / recombinant hepatitis B / yeast produce hepatitis B / several candidate acellular pertussis / culture-proven pertussis disease / immunodeficiency disorders / progressive debilitating infections / Bordetella pertussis / variola virus / disease / very serious disease / pertussis / B. pertussis / HPV / whole-cell pertussis / different acellular pertussis / fever / serious and common childhood respiratory disease / killed Bordetella pertussis / encephalitis / diseases / safe / effective pertussis / infectious viral DNA / infection / acellular pertussis / vaccine-associated injuries / routine smallpox / /
MedicalTreatment
immunization / vaccination / /
Organization
United States Public Health Service / National Institute of Health / World Health Organization / Food and Drug Administration / Food and Drug Administration Centers for Disease Control and Prevention / Institute of Medicine / Department of Veterans Affairs / Institute of Medicine Safety Reviews / Health Resources and Services Administration / Medicare / Department of Veterans Affairs Department of Defense / National Vaccine Program Office / Department of Defense / Department of Health and Human Services / /
Person
Helen Quill / Robert Ball / D. Jeffrey Kelman / Kirsten Vannice / M. Paul Gargiullo / P.H. George Curlin / Renata Engler / D. Tamara Overby / John Iskander / Karen Midthun / M.D. Jeanne Santoli / Geoff Evans / P.H. Barbara Mulach / H. Patrick Garman / Francine Goodman / M.D. Ronald Valdiserri / P.H. Florence Houn / Wayne Hachey / P.H. Bruce Gellin / Daniel Salmon / P.H. Charles Hackett / H.S. Nasrin Nabavi / Carmen M. Collazo-Custodio / H. Melinda Wharton / Kenneth Bart / /
Position
Executive / /
Product
Adverse Event Reporting System / Compensations / Manufacturing Process / Acellular Pertussis Vaccines / Investigational New Drug / Testing Vaccine / /
Vaccine Safety Activities at the Department of Health and Human Services